home / stock / adil / adil news

ADIL News and Press, Adial Pharmaceuticals Inc

Stock Information
Company Name: Adial Pharmaceuticals Inc
Stock Symbol: ADIL
Market: NASDAQ
Website: adialpharma.com
Menu
ADIL ADIL Quote ADIL Short ADIL News ADIL Articles ADIL Message Board
Get ADIL Alerts

News, Short Squeeze, Breakout and More Instantly...
ADIL - ADIL - Historical Price Movements Surrounding Earnings

2026-03-09 18:38:23 ET Adial Pharmaceuticals, Inc. (ADIL) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 2.29%. The average open to low on the day of earnings was -5.42%. The average op...
ADIL - Adial Pharmaceuticals reports FY results

2026-03-06 14:05:14 ET More on Adial Pharmaceuticals Seeking Alpha’s Quant Rating on Adial Pharmaceuticals Historical earnings data for Adial Pharmaceuticals Financial information for Adial Pharmaceuticals Read the full article on Seeking Alpha ...

ADIL - Adial Pharmaceuticals Reports 2025 Fiscal Year Financial Results and Provides Business Update

GLEN ALLEN, Va., March 06, 2026 (GLOBE NEWSWIRE) --  Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disor...

ADIL - Adial Pharmaceuticals Signs an Exclusive AD04 Collaboration Framework with Molteni Farmaceutici for Europe which Anticipates Nearly $60 Million in Potential Royalties and Milestones upon execution of a Definitive Agreement

GLEN ALLEN, Va., March 03, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of treatments for addiction and related disorders, today announced it has en...
ADIL - Expected US Company Earnings on Tuesday, March 3rd, 2026

GitLab Inc. (GTLB) is expected to report $-0.02 for Q4 2026 Ross Stores Inc. (ROST) is expected to report $1.88 for Q4 2026 Advantage Solutions Inc. (ADV) is expected to report $0.07 for Q4 2025 Hyster-Yale Inc. Class A (HY) is expected to report $-1.2 for Q4 2025 Versant Media Gr...

ADIL - ADIL - Historical Earnings Price Analysis

2026-03-02 17:33:38 ET Adial Pharmaceuticals, Inc. (ADIL) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in ADIL stock price following earnings has averaged ±2.95% , with a median of 2.6...

ADIL - Adial Pharmaceuticals Regains Full Compliance with Nasdaq Listing Requirement

GLEN ALLEN, Va., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL ) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, t...
ADIL - Adial Pharmaceuticals Highlights FDA Policy Direction That May Reduce Pivotal Trial Burden from Two Studies to One

GLEN ALLEN, Va., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL ) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, t...

ADIL - Adial Pharmaceuticals to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

GLEN ALLEN, Va., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL ) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, t...

ADIL - Adial Applauds Congressional Directive Advancing Alternative Clinical Trial Endpoints for Substance Use Disorders, Strengthening Regulatory Path for AD04

GLEN ALLEN, Va., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL ) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, t...
Next 10